Clinical ink, a provider in eSource solutions, as appointed Andrew Kraus as chief technology officer to lead the development of its expanding technology portfolio to support clinical trials.    “I am passionate about making a meaningful difference for patient by streamlining the clinical trials process,” said Kraus. “There is so much opportunity to simplify the capture of clinical data from patient. I’m excited to drive innovation as part of the Clinical ink team as we lead the industry in the...